sunitinib,cabozantinib,nivolumab,ipilimumab
merck,bms,pfizer
['nivolumab', 'sunitinib', 'cabozantinib', 'al 101', 'immotion,150', 'renal,(-adrenal)', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'javelin,renal,101', 'check,mate,9er', 'biomarker', 'cabo ', 'nivo', 'bristol', 'marker ', 'effector ']
 no prognostic nor predictive biomarker for nivolumab + cabozantinib v sunitinib for advanced renal cell carcinoma by in the phase 3 checkmate 9er trial. #gu23 
Oncólogo Clínico staff @IAF_Fleming. Miembro @SelnetH2020 @aaoncoclinica. Interesado en #GUcsm. #clinicaltrials. #Immunotherapy #PrecisionMedicine #oncoalert